Cagrilintide CGL10 10mg*10vials

Cagrilintide CGL10 10mg*10 vials is a high-purity, high-quality research-grade dual-target amylin and calcitonin receptor agonist, an upgraded high-concentration version of the Cagrilintide research peptide series. This 10mg high-dose formulation features an optimized stable molecular structure and excellent receptor binding selectivity, designed specifically for advanced, high-intensity preclinical metabolic studies. Utilizing multi-stage pharmaceutical-grade precision purification and a professional vacuum lyophilization process, the lyophilized powder exhibits excellent molecular stability, complete solubility, and strict batch-to-batch consistency. This effectively avoids molecular inactivation and efficacy reduction during storage and experimental reconstitution, fully meeting the stringent quality and precision standards of professional laboratories, drug research institutions, and long-term metabolic mechanism studies.

Product Function and Research Value

As a potent and long-acting amylin analogue research reagent, Cagrilintide CGL10 can dually activate the amylin and calcitonin receptor signaling pathways, thereby comprehensively regulating systemic metabolic homeostasis. In laboratory studies, it is widely used to investigate core mechanisms including inhibiting gastric emptying, significantly suppressing appetite, reducing calorie intake, activating adipocyte lipolysis, and long-term regulation of body weight balance. Compared to the standard low-dose canagreyide, the 10mg high-concentration CGL10 version has stronger pathway activation capabilities, more thorough metabolic intervention, and more durable physiological effects. Its precise high-dose linear relationship significantly reduces experimental error, resulting in highly stable and reproducible research data. This specification is ideal for advanced preclinical research projects such as high-intensity metabolic remodeling experiments, chronic obesity mechanism studies, high-load energy metabolism regulation, and complex peptide synergistic intervention studies.

Core Product Advantages

1. Dual-Target Synergistic Metabolic Regulation: Simultaneously activates amylin and calcitonin receptors to achieve dual-pathway metabolic regulation, providing a more comprehensive metabolic regulatory effect compared to traditional single-target metabolic peptides.

2. 10mg High-Concentration Upgrade Specification: Higher content per vial, stronger biological activity, and longer duration of experimental effect, fully meeting the experimental needs of high-intensity interventions and long-term metabolic modeling.

3. Excellent solubility and molecular stability: High-quality lyophilized powder dissolves rapidly and completely in antibacterial water, resulting in uniform solution concentration and ensuring the purity of experimental variables, unaffected by impurities.

4. High purity and batch-to-batch consistency validated by HPLC: Produced using standardized purification procedures and undergoing rigorous quality testing, ensuring stable bioactivity across all batches, thus obtaining accurate and reliable research results.

5. Standard sterile laboratory packaging: Each box contains 10 individually sterile vials with complete COA certification, ideal for academic laboratory research, preclinical drug development, and global bulk wholesale procurement.

Cagrilintide CGL10 10mg*10 vials is a high-concentration dual-target amylin receptor agonist research peptide suitable for high-intensity metabolic and body composition studies. It features enhanced receptor activation, stable molecular properties, and long-lasting metabolic regulation, supporting laboratory studies in areas such as appetite control, gastric emptying regulation, and lipid metabolism remodeling. HPLC-verified and with complete COA certification, it is available for global wholesale.